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Abstract 
 
Synthetic oligonucleotides are ubiquitously found in most laboratories since solid-phase 
synthesis protocols have become highly optimized. These protocols make it possible to 
synthesize a large variety of modified oligonucleotides. As one example, we will review 
some of the developments regarding oligonucleotide synthesis from our own group. In 
particular, we will describe the synthesis of oligonucleotides carrying non-natural bases, 
of oligonucleotide-peptide conjugates, and of modified oligonucleotides used in the 
assembly of nanomaterials.  
 
  
Introduction  
The identification of DNA as the basis of genetic material and the elucidation of its 
structure stimulated attempts to undertake the complex synthesis of defined 
oligonucleotides. In 1955, two years after the report on the double-helix structure by 
Watson and Crick, the first synthesis of a dinucleotide was  published (Michelson and 
Todd, 1955). During the next 20 years solution-phase methods were used to synthesize 
oligonucleotides employing the "phosphodiester" approach developed by the Khorana 
group (Khorana, 1979).   
The "phosphotriester" methodology was subsequently developed (Reese, 1978) and 
afterward, solid-phase methodology was introduced. Immediately after Merrifield’s 
solid-phase synthesis of the tetrapeptide Leu-Ala-Gly-Val (Merrifield, 1963), Letsinger 
synthesized an oligonucleotide using solid-phase supports  (Letsinger and Mahadevan, 
1965). Although it was not until the end of the 1970s that solid-phase protocols were 
developed, with certain improvements, and they became the method of choice for the 
preparation of oligonucleotides. The newly developed phosphotriester methodology was 
suitable for solid-phase synthesis, prompting development of linkers and supports. In 
the mid-1970s synthetic cycles became automated and HPLC began to be used for the 
purification of oligonucleotides. In addition, DNA synthesizers appeared and 
oligonucleotides became available for biochemical and molecular biology studies. 
At the same time that automation of the DNA synthesis was underway, the Letsinger 
group realized the potential of phosphorous III derivatives, exploiting their exceptional 
reactivity (Letsinger and Lunsford, 1976) to develop the phosphite-triester method. 
Shortly afterwards, Beaucage and Caruthers developed the nucleoside phosphoramidites 
(Beaucage and Caruthers, 1981) which could be synthesized, stored, and activated by 
tetrazole to yield phosphite-triester intermediates that were subsequently transformed 
via oxidation to phosphate-triester (Fig. 1). Nowadays, phosphoramidite derivatives 
remain the most widely used for oligonucleotide synthesis, allowing for the preparation 
of oligonucleotides with natural phosphodiester bonds or with modified phosphates 
such as phosphorothioates. A large number of developments in nucleic acid chemistry 
achieved with the phosphoramidite approach can be found in the superb reviews by 
Beaucage and Iyer (Beaucage and Iyer, 1992, 1993a, b,c).  
 
Figure 1 
 
In solid phase methods, the 3'-end of the first nucleoside is attached covalently to a 
polymeric support. In this way, the oligonucleotide chain grows on the polymeric 
support with the excess chemicals used during synthesis washed out, thus simplifying 
the synthetic process (Figure 1). In addition, solid-phase techniques made possible the 
automation of the synthetic process and oligonucleotide synthesizers became 
increasingly available to most laboratories.  
Although the supports used in the first protocols employing phosphotriester 
methodology were similar to peptide synthesis (polystyrene and polyamide), machine-
assisted synthesis of oligonucleotides was soon adopted for silica-derived supports such 
as controlled-pore glass (CPG) (Matteucci and Caruthers, 1981, Gait, 1985, Agrawal, 
1993, Narang, 1987, Caruthers et al., 1987). These supports give better yields, possess 
good mechanical properties, and do not swell in organic solvents. Highly cross-linked 
polystyrene was subsequently developed for small-scale use (20-200 nmol) due to its 
hydrophobic properties and the lack of reactivity of its surface (McColum and Andrus, 
1991). For large-scale synthesis, several alternative supports have been described, such 
as those composed of polystyrene (Montserrat et al., 1994) or polystyrene-
polyethyleneglycol (Wright et al., 1993). 
Here, we will review some of the developments in oligonucleotide synthesis originating 
with our own group. As my Ph. D. thesis addressed solid-phase peptide synthesis (Giralt 
et al., 1981,  Giralt et al., 1986), an important part of our research focuses on synthetic 
methodology for the preparation of modified oligonucleotides. However, due to the 
important biological properties of DNA, these synthetic efforts have been mainly 
directed towards producing compounds that solve biological and/or structural questions.  
 
RESULTS AND DISCUSSION 
 
The properties and synthesis of oligonucleotides carrying modified bases of 
biological and structural interest. 
The phosphoramidite approach allows for the preparation of oligonucleotides containing 
not only the natural bases, but also a large number of non-natural nucleosides. 
Oligonucleotides containing non-natural bases are being used in structural studies to 
analyze DNA-DNA and DNA-protein interactions as well as in model compounds for 
the study of mutagenesis and the repair of mutagenic lesions (Basu and Essigmann, 
1988).  
 
Structural elucidation of the mutagenic properties of 2-aminopurine, 5-fluoro and 5-
bromouracil 
2-Aminopurine (AP)  is an adenine (A) isomer in which the exocyclic amino group 
occurs at position 2 instead of position 6. While AP preferentially forms base pairs with 
thymine (T) during DNA synthesis, it may also form base mispairs with cytosine (C), 
causing A.T to G.C transitions. The substitution of the methyl group at position 5 of 
thymidine with bromine or fluorine yield nucleosides that exert important 
chemotherapeutic activity. As thymidine analogues, 5-fluoro  (FU) and 5-bromouracil 
(BrU) derivatives noy only form base pairs with adenine, but also, base mispairs with 
guanine (G). The mutagenic properties of AP, FU, and BrU stem from the formation of 
anomalous base pairs with natural bases, primarily resulting in the higher stabilities of 
AP.C, FU.G and BrU.G base mispairs. To investigate this latter phenomenon, defined 
sequence oligonucleotides containing these modified bases were prepared and studied 
using NMR techniques. Three possible structures were proposed for these mispairs  
(Fig. 2), including those involving a neutral wobble structure, a rare tautomer (enol for 
FU and BrU and imino for AP), and ionized forms (the protonated form for AP and the 
deprotonated form for BrU and FU). NMR studies on DNA duplexes carrying these 
modified mispairs show the presence of a pH-dependent equilibrium between a wobble 
geometry and an ionized structure in Watson-Crick geometry (Fagan et al., 1996, 
Gargallo et al., 2001, Law et al., 1996, Sowers et al., 1986, 1988, 1989a, 1989b, 2000). 
For 5-substituted uracil derivatives, the ionized structure was shown to be responsible 
for the higher mispair frequency (Yu et al., 1993).  
 
Figure 2 
 
To prepare those oligonucleotides carrying AP, we prepared a protected derivative (Fig. 
3, Eritja et al., 1986a). First, 2-aminopurine 2’-deoxyriboside was synthesized by 
transglycosylation (Sowers et al., 1989c). The N-isobutyryl derivative was then 
prepared by modifying the transient protection procedure (Ti et al., 1982). This method 
allowed for the preparation of DNA duplexes carrying the four nitrogen atoms in the 
AP.C mispair with 15N, which is essential for NMR studies (Sowers et al, 1989b and 
1989c). An easier method for the selective introduction of 15N labels at the exocyclic 
position of AP was developed (Acedo et al., 1994). The key step of this method is the 
preparation of the phosphoramidite (derivative) of 2-fluoropurine 2’-deoxyriboside. 
This derivative can be incorporated at a specific position within an oligonucleotide 
sequence and during deprotection can be transformed to the desired 15N labelled 
nucleoside (Fig. 3). This strategy, know as the convertible nucleoside (MacMillan and 
Verdine, 1991) or postsynthetic substitution approach (Xu et al., 1992), has been used 
for introduce sensitive bases and other groups that are difficult to incorporate using the 
classical method.  
 
Figure 3  
 
At present, the phosphoramidite derivative of 2-aminopurine is prepared by reduction of 
guanosine derivatives (Figure 3, McLaughlin et al., 1988, Connolly, 1992, Schmidt and 
Cech, 1995, Fujimoto et al., 1996). It is then used as a fluorescent adenine substitute to 
study those proteins that interact with DNA (Beechem  et al., 1998, Bloom et al., 1994, 
Holz et al., 1998, Raney et  al., 1994). 
 
Studies on non-natural bases that may base pair equally well with the four natural 
bases (universal base) 
A particular problem on the use of oligonucleotides as probes involves finding a 
nucleoside and non-nucleoside derivative that can base pair equally well with the four 
natural bases to act as an (universal base). This is needed to prepare DNA probes in 
which the nucleic acid sequence is not completely known. This often occurs when 
designing oligonucleotide probes from protein sequences due to degeneration of the 
genetic code. 2’-Deoxyinosine (Fig. 4a) was the first compound studied and remains 
one of the most used for this purpose (Ohtsuka et al., 1985). Its ribonucleoside 
derivative, inosine, was found in t-RNA at the third position of the anticodon, and 
proved capable of pairing the A, C and U bases of the anticodon. Oligonucleotides 
carrying 3-nitropyrrole (Fig 4e, Nichols et al. 1994) and 5-nitroindole (Fig 4f, Loakes 
and Brown, 1994, Loakes et al., 1995) at several sites were used as primers for 
sequencing and polymerase chain reaction (PCR, Mullis et al. 1986). These analogues 
are designed to maximize base stacking, thereby minimizing hydrogen-bonding 
interactions.  
 
Figure 4 
 
Another approach is to modify 2’-deoxyinosine in the hopes of obtaining better base 
pairing properties. Introduction of a hydrogen bond acceptor in position 2 yields a 
purine analogue derived from 2’-deoxyinosine that contains the configuration of 
hydrogen binding groups: acceptor-donor-acceptor. This allows the construction of 
base-pairing structures with two hydrogen bonds for the four natural bases. The 
preparation of synthetic oligonucleotides containing xanthine (Fig. 4b), the first base 
analogue of this type, was reported (Eritja et al., 1986b). Xanthine-containing 
oligonucleotides were found to have a low melting temperature under neutral pH 
conditions, due to the ionization of xanthine at a similarly neutral pH (pKa of xanthosine 
5.5). It was also shown that xanthine base pairs become more stable at pH 5.5 (Eritja et 
al., 1986b).  
Xanthine-containing oligonucleotides are of added interest since xanthine may be 
present in DNA as a by-product of the spontaneous guanine deamination. Incorporation 
of base mispairs opposite template xanthine sites by Drosophila DNA polymerase α 
showed that T and C were incorporated opposite xanthine. These data do not correlate 
with the relative thermodynamic stabilities obtained from melting curves suggesting 
that DNA polymerase misinsertion rates are greater when the base pair forms in 
accordance with Watson-Crick geometry (Eritja et al., 1986). This hypothesis has been 
further studied by several authors and excellent reviews are available (Kool, 2001 and 
Benner, 2004). 
Substitution of the keto group by a nitrogen atom at position 2 in xanthine yields a base 
analogue, 2-azahypoxanthine (Fig. 4c) that shares the same acceptor-donor-acceptor 
configuration, albeit with a higher pKa (pKa of 2-azainosine 6.8). Attempts to synthesize 
oligonucleotides containing 2-aza-2’-deoxyinosine (using a protected derivative with 
the N,N-diphenylcarbamoyl group) failed, due to an unexpected side-reaction of the 
protected derivative during the final ammonia treatment (Fernández-Forner et al., 1991). 
Protection of 2-azahypoxanthine moiety with the photolabile 2-nitrobenzyl group 
allowed for the preparation of oligonucleotides containing 2-azahypoxanthine (Acedo et 
al., 1995). Melting curves for duplexes carrying 2-azahypoxanthine paired with the four 
natural bases proved that 2-azahypoxanthine base pairs were less stable than perfectly 
matched duplexes, although little variation was evident among different bases (Acedo et 
al., 1995).  
A similar result was found during the synthesis of oligonucleotides carrying 8-amino-
2’-deoxyinosine (Fig. 4d, Cubero et al., 2001). As explained below, the presence of an 
amino group at position 8 of the purines not only stabilizes DNA triplexes, but also 
induces a small destabilization of the duplex carrying the 8-aminohypoxanthine-C base 
pair. In this way, the differences in the melting temperatures of the duplexes carrying 8-
aminohypoxanthine paired with the four natural bases were similar to those reported for 
3-nitropyrrole and 5-nitroindole. Only 8-aza-7-deaza-2’-deoxyadenosine (Seela and 
Debelak, 2000) had better binding properties than 8-aminohypoxanthine (Cubero et al. 
2001).   
 
Preparation of oligonucleotides carrying ammonia sensitive bases. Synthesis of 
oligonucleotides carrying O4-alkylthymidines and 5-azacytidine 
 
The carcinogenicity of N-nitroso alkylating agents such as nitrosoureas and 
nitrosoamines is believed to be mediated by alkylation of DNA nucleobases, in 
particular O6-alkylguanine and O4-alkylthymine. To study the biological role of O4-
alkylthymine residues in DNA, it was important to develop procedures for incorporating 
these lesions in synthetic DNA. These compounds are difficult to incorporate as they 
are very sensitive to the ammonia used for deprotecting the synthetic DNA (Singer et 
al., 1978) that yields 5-methylcytosine derivatives (Fig. 5a). For those oligonucleotides 
carrying O4-methylthymine this obstacle was overcome by using methoxide ions 
(methanol and 1,8-diazabiciclo[5.4.0]undec-7-ene, DBU), which removed the base-
protecting groups (Fig. 5b, Li et al., 1987, Borowy-Borowsky and Chambers, 1989). 
This strategy was extended to oligonucleotides carrying O4-ethyl, O4-propyl (Roelen et 
al., 1992) and O4-benzylthymine (Fábrega et al., 1995) when more labile groups, such 
as phenoxyacetyl or t-butylphenoxyacetyl, were used to protect nucleobases. In this 
way, the lower nucleophilicity of the corresponding alcoxide ions can be offset. 
However these methods proved ineffective for other O4-alkylthymine residues.  
 
Figure 5  
 
A more general method for the preparing oligonucleotides that carry O4-alkylthymines 
was thus proposed (Fernández-Forner et al., 1990). In this method, the (p-
nitrophenyl)ethyl and the (p-nitrophenyl)ethoxycarbonyl (NPE, NPEOC) groups 
(Himmelsbach et al., 1984) were used to protect natural nucleosides. Developed by 
Pfleiderer’s group (Pfleiderer et al., 1986), these groups are removed by a β-elimination 
mechanism, which is carried out under non-nucleophilic conditions suitable for the 
integrity of O4-alkylthymine residues. This method has been successfully used for the 
preparation of oligonucleotides carrying O4-ethyl (Fernández-Forner et al., 1990), O4-
propyl (Eritja et al., 1992), and O4-butylthymine (Aviñó et al., 1995).  
During development of this procedure we found that short oligonucleotides of good 
purity could be obtained but that those longer than 10 bases contained several impurities 
and exhibited low yield. One cause of these problems stemmed from base alkylation by 
acrylonitrile, formed during the removal of the cyanoethyl phosphate protecting group 
(Eritja et al., 1992). The use of the less reactive (p-nitrophenyl)ethyl phosphate group 
and/or(?) the utilization of thymine as scavenger in the deprotection solution minimized 
base alkylation such that longer and cleaner oligonucleotides could be obtained under 
conditions compatible with ammonia-sensitive compounds (Aviñó and Eritja, 1994).  
A second problem was the stability of both the succinyl and the (o-nitrophenyl)ethyl 
linkages (Eritja et al., 1992) to DBU solutions. Although these linkages are reportedly 
labile to DBU, we observed that the cleavage efficiency of oligonucleotides on these 
supports were length- and sequence-dependent and that thymine-rich oligonucleotides 
were released from supports in very low yields (Aviñó et al., 1996). The use of the more 
labile oxalyl (Alul et al., 1991) linker and thymine as scavenger employing NPE 
protection provided the best results when preparing oligonucleotides carrying ammonia-
sensitive moieties (Aviñó et al., 1996). When compared with standard amide protection 
this method is less efficient and requires the preparation of protected monomers that are 
not commercially available. Despite such inconveniences, it provides modified 
oligonucleotides that cannot be obtained through standard procedures.  
A clear example of the application of this method in the preparing oligonucleotides that 
carry highly sensitive nucleobases was the synthesis of oligonucleotides carrying 5-
azacytosine residues (Güimil García, R. et al., 2001). 5-Azacytosine is a cytosine analog 
in which the carbon at position 5 of the pyrimidine ring is replaced by a nitrogen atom. 
Both ribonucleoside and 2’-deoxyribonucleoside are potent cytotoxic agents used for 
the treatment of several cancer types with varying degrees of success. As result of their 
incorporation into DNA, these drugs can demethylate DNA using a unique mechanism 
of action that affects gene regulation. To elucidate the molecular basis underlying their 
inhibitory properties, we needed to synthesize oligonucleotides carrying this base. 
However the triazine ring´s instability to ammonia precluded the use of standard 
phosphoramidite protocols. Thus, these modified oligonucleotides could only be 
prepared using the NPE and NPEOC groups to protect the exocyclic amino functions. 
These groups could then be removed under conditions that were not detrimental to the 
integrity of the 5-azacytosine ring (Güimil García, R. et al., 2001). 
 
Non-radioactive labelling and oligonucleotides as specific inhibitors of gene 
expression 
Recent advances in DNA techniques have led to the widespread use of specific nucleic 
acid hybridization probes as an alternative methodology for detecting human infectious 
diseases. Polymerase Chain Reaction (PCR) has increased the clinical uses of DNA-
based diagnostic tests by producing sufficient target sequences such that simple 
methods can be used to identify pathogens from crude DNA preparations (Mullis et al., 
1986). In parallel, a large effort has been undertaken to develop non-radioactive DNA 
labelling systems and immobilization methods for handling large numbers of samples. 
In the oligonucleotide field, these applications have triggered the development of 
nucleosidic and non-nucleosidic phosphoramidite derivatives for the functionalization 
of oligonucleotides. Indeed, these derivatives have permitted the efficient preparation of 
oligonucleotides carrying fluorescent compounds, biotin, enzymes as well as 
intercalating, and DNA cleaving groups (Goodchild, 1990).  
At the same time, short oligonucleotides were shown to be useful for the selective 
inhibition of gene expression (Zamecnik and Stephenson, 1978). To achieve the desired 
inhibition, antisense oligonucleotides complementary to target mRNA should penetrate 
inside the cells and bind to their complementary sequence before exonuclease activity 
degrades them. A large variety of modified oligonucleotides have been designed to 
enhance nuclease resistance. The synthesis and applications of modified 
oligonucleotides as inhibitors of gene expression has been extensively reviewed 
(Agrawal, 1993 and 1994, Braasch and Corey, 2002, Crooke and Lebleu, 1993, Thuong 
and Helene, 1993, Uhlmann and Peyman, 1990, Sproat, 1995). One alternative to 
antisense oligonucleotides are the short interfering double-stranded RNA molecules 
(siRNA, Elbashir et al., 2001 and Achenback et al., 2003) that can be used to inhibit 
expression of a particular gene by degrading its mRNA using RNA interference 
machinery (Craig and Mello, 1998). 
 
Synthesis of oligonucleotide-peptide conjugates 
Covalent attachment of poly(L-Lysine) to oligonucleotides enhanced the inhibitory 
properties of oligonucleotides (Lemaitre, 1987) by improving cellular uptake. This led 
us to study the use of peptide sequences for in vivo targeting of antisense 
oligonucleotides. Among the first peptide sequences studied were nuclear localization 
sequences (NLS, Fig. 6, Eritja et al., 1991), which are rich in lysines.  
 
Figure 6  
 
The preparation of oligonucleotide-peptide conjugates poses an interesting challenge 
since the conventional protection schemes are not compatible. For example, amide-type 
protecting groups are used to protect nucleobases. These protecting groups are removed 
by ammonia under conditions that could hydrolyze peptide bonds or cause unwanted 
side-reactions such as racemization or aspartimide formation. However, all standard 
protection schemes in solid-phase peptide synthesis use acid treatments which could 
cause partial depurination of DNA. Two different strategies that overcome these 
problems have been described: 1) the post-synthetic conjugation approach (Fig. 6, Eritja 
et al., 1991); and 2) the stepwise solid-phase synthesis approach (Fig. 7, de la Torre et 
al., 1994 and 1999). The synthesis and applications of oligonucleotide-peptide 
conjugates has been extensively reviewed (Eritja, 2000, Tung and Stein, 2000, Gait, 
2003, Grandas et al., 2004, Venkatesan et al., 2006). 
 
Figure 7 
 
In the post-synthetic conjugation approach, although the oligonucleotide and the peptide 
are built in a separate support using standard protocols, they are conveniently 
functionalised for linkage following synthesis. In the stepwise solid-phase approach the 
oligonucleotide-peptide conjugate is prepared in a single support using special 
protecting groups and modified protocols that minimize unwanted side-reactions (de la 
Torre  et al., 1994 and 1999). In a comparative study we demonstrated that both 
methodologies yielded similar results during the preparation of oligonucleotides 
carrying NLS sequences (de la Torre et al., 1999, Eritja, 2000). We believe that the 
post-synthetic conjugation approach is the best choice for preparing small amounts of 
oligonucleotide-peptide conjugates in which the peptide portion is a protein or a large 
peptide. The stepwise solid-phase approach will be useful in preparing large amounts of 
conjugates carrying short peptide sequences. Oligonucleotide-peptide conjugates 
carrying nuclear localization sequences have been prepared by several authors (Eritja et 
al., 1991, de la Torre et al., 1999, Reed et al., 1995, Zanta et al., 1999). 
Oligonucleotides complementary to the mRNA of calmodulin carrying NLS sequences 
were found inactive in the freshwater ciliate Paremecium (Reed et al., 1995). A single 
nuclear localization signal sequence in a 3.3-kbp luciferase gene has been shown to 
greatly enhance transfection (Zanta et al., 1999). We also studied the effects of the 
peptide sequence upon the binding properties of oligonucleotides, especially vis-à-vis 
mismatch discrimination. To this end, oligonucleotides complementary to a mutated 
Ha-ras oncogene (Duroux et al., 1995) carrying NLS sequences were prepared (de la 
Torre et al., 1999). These oligonucleotide-peptide conjugates hybridized with 
complementary sequences possessing a slightly higher stability than unmodified 
sequences. This is consistent with the results obtained with conjugates carrying basic 
amino acids (Zhu et al., 1993, Harrison and Balasubramanian, 1998, Marchán et al. 
2004). However, the binding of conjugates carrying nuclear localization sequences to 
the target 27-mer RNA proved 10-fold less efficient (de la Torre et al., 1999). However, 
despite their less efficient binding, conjugates carrying the nuclear localization sequence 
can distinguish single-mutated RNA from wild-type RNA (de la Torre et al., 1999).  
Oligonucleotides carrying the somatostatin analog, Tyr3-octreotate, were prepared 
(Mier et al., 2000). Somatostatin is a cyclic tetradecapeptide found in the hypothalamus 
that exerts inhibitory effects on the secretion of growth hormones. Octreotide is a cyclic 
octapeptide derived from somatostatin boasting an improved specificity. Somatostatin 
receptors are overexpressed by a variety of neoplastic tissues, especially endocrine 
tumors. The introduction of octreotate into oligonucleotides is designed to increase the 
uptake of anticancer oligonucleotides by tumor cells. Oligonucleotide 
phosphorothioates carrying octreotate were prepared by post-synthetic conjugation. An 
octreotate derivative with a maleimido group at the N-terminal position was place in 
reaction with a thiol-oligonucleotide to obtain the desired conjugates. The resulting 
conjugates exhibited both a high binding affinity to somatostatin receptors and good 
hybridisation properties (Mier et al., 2000). Nevertheless, in vivo cellular uptake, as well 
as accumulation in tumor tissues, proved better using the peptide nucleic acid (PNA, 
Hyrup and Nielsen 1996, Uhlmann et al., 1998) derivative instead of the 
phosphorothioate (Mier et al., 2003).  
Moreover, we have attempted to introduce peptide sequences into oligonucleotides as a 
type of non-radioactive labelling system. Although this is more difficult than 
introducing other non-radioactive labels such as biotin, fluorescein, or digoxigenin, the 
great diversity of antibodies raised against peptides led us to consider oligonucleotide-
peptide conjugates as an alternative labelling system of great potential, particularly in 
multiple hybridisation experiments. To test these possibilities we prepared 
oligonucleotides carrying a c-myc tag-sequence (Gottschling et al., 1998). In preparing 
the oligonucleotide-peptide conjugates we used both the post-synthetic conjugation 
(Gottschling et al., 1998) and stepwise approaches (Frieden et al., 2004). The conjugates 
were recognized by an anti-c-myc monoclonal antibody while detection was achieved 
through interaction with a peroxidase-conjugated antibody and a chemiluminescent 
substrate, as well as with gold-labeled antibody and inductively coupled plasma - mass 
spectrometry (ICPMS) (Merkoçi et al., 2005). Similarly, peptide nucleic acids (PNA) 
were labelled by the addition of the same c-myc peptide sequence (Gottschling et al., 
2000). The resulting conjugates exhibited a higher affinity to complementary DNA than 
unmodified oligonucleotides (Gottschling et al., 2000). 
In the stepwise approach, oligonucleotide-peptide conjugates are prepared by stepwise 
addition of amino acids and nucleobases in solid phase on the same solid support. This 
is usually performed by first assembling the peptide using t-butoxycarbonyl (Boc) -
protected amino acids with base labile groups such as fluoren-9-ylmethyl (Fm), fluoren-
9-ylmethoxycarbonyl (Fmoc), and trifluoroacetyl (TFA) groups to protect side chains. 
Although these protocols generate oligonucleotide-3’-peptide, they could not be used to 
incorporate peptides at the 5’ end or in the middle of the oligonucleotide sequence. 
Recently, a method for the solid-phase synthesis of oligonucleotide-5’-peptide 
conjugates has been described. It is based on the use of the 2-(biphenyl-4-yl)propan-2-
yloxycarbonyl (Bpoc) group for the protection of the α-amino group (Zaramella et al., 
2004). These groups can be removed under mildly acidic conditions suitable for DNA. 
In addition, we have developed an efficient method to synthesize short oligonucleotide-
5’-peptide conjugates via stepwise synthesis using commercially available Fmoc-
protected amino acids (Ocampo et al., 2005). Although the Fmoc-removal conditions 
are not orthogonal to the base-labile cyanoethyl protection of DNA phosphotriester 
moieties, we found that the presence of unprotected phosphate groups did not hinder the 
assembly of small peptide sequences on oligonucleotide supports. Those groups labile 
to mild acidic conditions (such as 1% trifluoroacetic acid) were used to protect side 
chains of Nα-Fmoc-protected amino acid side chains (Ocampo et al., 2005). 
 
Triplex-stabilizing properties of 8-aminopurines 
Oligonucleotides can interact in a sequence-specific manner to homopurine-
homopyrimidine sequences of duplex and single-stranded DNA and RNA to form 
triplexes (Thuong and Hélène, 1993). Nucleic acid triplexes have potential applications 
in diagnostics, gene analysis, and therapy (Thuong and Hélène, 1993, Soyter and 
Potoman, 1996, Vasquez and Glazer, 2002, Robles et al., 2002) Depending on the 
composition and orientation of the third strand vis-à-vis the central homopurine 
Watson-Crick strand, triplexes are classified into two main categories: (i) parallel and 
(ii) antiparallel (Thuong and Hélène, 1993). 
The most-well characterized parallel triplex is the one formed between a double-
stranded homopurine-homopyrimidine helix (duplex DNA) and a single-stranded 
homopyrimidine track (triplex-forming oligonucleotide). In this type of triple helix, the 
triplex-forming oligonucleotide binds to the major groove (parallel to the homopurine 
strand of Watson-Crick double-helical DNA) via Hoogsteen hydrogen bonding, and is 
stabilized under acidic conditions. 
In the antiparallel triplexes, the third strand composed of purine bases binds _in a pH 
independent and antiparallel fashion to the homopurine duplex strand via reverse-
Hoogsteen hydrogen bonds.  
The introduction of an amino group at position 8 of the Watson-Crick purines (A, G and 
hypoxanthine, Fig. 8) produces a high stabilization of parallel triplexes (Kamai et al., 
1998, Güimil-García et al., 1998, Güimil-García et al., 1999, Soliva et al., 2000, Soliva 
et al., 2001). While the stabilizing properties of these analogues were hypothesized 
some thirty ago (Hattori et al., 1975 and 1976), experimental data was not then available 
due to self-aggregation of homopolymers containing these bases. Recently, the 
preparation of oligonucleotides carrying 8-aminopurines was described and a high 
stabilization effect on triplex was found (Kamai et al., 1998, Güimil-García et al., 1998, 
Güimil-García et al., 1999, Soliva et al., 2000, Soliva et al., 2001). The triplex-
stabilization properties of the amino group at position 8 results from a combined effect 
of the gain of one Hoogsteen purine-pyrimidine H-bond (Fig. 8) and the propensity of 
the amino group to be integrated into the ‘spine of hydration’ located in the minor-
major groove of the triplex (Güimil-García et al., 1998).  
 
Figure 8 
 
Sequence-specific triple-helix structures can also be formed by DNA clamps. Parallel-
stranded DNA clamps consist of purine residues linked to a homopyrimidine chain of 
inverted polarity by 3’-3’ or 5’-5’ internucleotide junctions (Fig. 9, van de Sande et al., 
1988), which interact with single-stranded homopyrimidine nucleic acid targets 
(Kandimalla and Agrawal, 1996). In this type of triplex, the clamp homopurine strand 
binds the homopyrimidine target through Watson-Crick bonds whereas the clamp 
homopyrimidine strand, which binds via Hoogsteen bonding, is stabilized under acidic 
conditions. The stability of triple helices has been enhanced by replacing natural bases 
with some modified bases such as 8-aminopurine residues (Aviñó et al., 2001, Aviñó et 
al., 2002, Aviñó et al., 2004). Their presence has also stabilized Hoogsteen parallel-
stranded duplex structure (Aviñó et al., 2001, Cubero et al., 2002).  
 
Figure 9 
 
This same strategy has been proven to generate stable antiparallel triplexes using 
purine-rich clamps as templates (i.e. antiparallel-clamps). Antiparallel clamps formed 
by a G,A- or G,T-Hoogsteen sequence linked to a polypurine sequence carrying 8-
aminopurines have also been prepared (Aviñó et al., 2003) and shown to form more 
stable triplexes if 8-aminoguanine is present in the purine Watson-Crick position. The 
presence of 8-aminoadenine only acted as stabilizing agent in antiparallel clamps 
carrying G,T-Hoogsteen strand (Aviñó et al., 2003). 
The increased binding properties of clamps carrying 8-aminopurines may be of special 
interest for the development of applications based on triple-helix formations. One of the 
first such to be studied involved capture of the cauliflower mosaic virus 35S promoter 
sequence by 8-aminopurine oligonucleotide clamps (Nadal et al. 2005). The presence of 
this sequence serves as a marker for genetically modified organisms (GMO) in food. 
The cauliflower mosaic virus 35S promoter sequence features a 12-base polypyrimidine 
target. Binding of oligonucleotide clamps was prevented by the target’s secondary 
structure. This problem was solved with a new strategy based on the addition of a tail 
sequence to a Watson-Crick strand such that modified clamps were able to form triple 
helices with structured DNA or RNA molecules. This tail-clamp strategy was shown to 
overcome structural interferences, while simultaneously increasing the stability of 
triplex formation to a high degree.  
A similar result was found during the development of capture probes for the detection 
of bacteria on food. We synthesized parallel tail-clamps designed to bind with Listeria 
innocua iap mRNA sequences containing a polypyrimidine track (Nadal et al., 2006). 
Our aim was to obtain optimum conditions for the triplex affinity capture of Listeria 
innocua iap mRNA sequences in order to develop new detection methods for pathogens 
based on the specific identification of their nucleic acids. In our study, we explored the 
effects of pH on the interaction of parallel tail-clamps with their target by UV thermal 
melting analysis. In addition, we optimized a triplex affinity capture assay capable of 
recovering iap mRNA molecules from a total RNA solution purified from L. innocua 
cells in a sequence-specific manner. Optimal results were obtained with tail-clamps 
carrying 8-aminoadenine moieties under neutral pH conditions: 45% of the iap mRNA 
molecules from a total RNA solution were captured (Nadal et al., 2006). 
 
Synthesis of oligonucleotides for use in the assembly of nanomaterials. 
There is a considerable interest in the assembly properties of biopolymers for the 
construction of nanomaterials. In this way, synthetic oligonucleotides have been used as 
templates for the assembly of inorganic nanocrystals, especially gold nanoparticles 
(Mirkin et al., 1996, Alivisatos et al., 1996). The hybridization properties of the 
oligonucleotides allow for the assembly of gold nanoparticles in dimensions based on 
the length of the oligonucleotides (Mirkin et al., 1996) and the formation of three-
dimensional networks (Alivisatos et al., 1996) that have special optical properties used 
for monitoring DNA hybridization (Storhoff et al., 1999). Oligonucleotides designed to 
form cruciform structures have been used to produce two-dimensional networks 
(Seeman, 2003, Seeman and Lukerman, 2005). In addition, the fabrication of metal 
nanowires templated by DNA has been described (Braun et al., 1998). DNA from one 
phage was fixed between two gold electrodes (12-16 μm) using short oligonucleotides 
immobilized to the electrodes by thiol groups. The building of a silver nanowire was 
achieved by binding silver ions to phosphate groups of DNA and using a reducing agent 
to convert the silver ions to silver (Braun et al., 1998). 
 A flexible method for the fabrication of gold nanostructures using oligonucleotide 
derivatives  
From the fabrication of the first chips in the 1950s to the present the density of the 
functional units per surface unit has doubled every 3-4 years. This has been possible 
thanks to technological advances that allowed for the miniaturization of circuits. 
However, the actual technologies derived from photolithography are reaching their 
physical limits while, conversely, chemists and biologists are working with larger and 
larger biomolecules. For these reasons, it is believed that in the near future, circuitry 
may be prepared using biomolecules that will order the nanomaterials in solution. The 
resulting structures will then be settled into the spaces produced by photolithography.  
One promising biomolecule is DNA since it forms lineal structures composed of two 
strands with known self-assembling properties. Moreover, there is a solid methodology 
to prepare DNA strands up to 100 bases (about 30 nm of length).  
In particular, we were interested in the preparation of synthetic DNA derivatives 
designed to assemble a molecular wire between two or three gold electrodes, which are 
needed to address individual nanoparticles from macroscopic electrodes (Iacopino et al., 
2003, Ongaro et al., 2004, Stanca et al., 2005, Stanca et al., 2006). Synthetic 
oligonucleotides were used to prepare the molecular wires, offering the possibility to 
introduce modifications at any predetermined position.  
The proposed structure for the simplest target molecule consists of three elements 
having different roles: anchoring, extension, and recognition (Fig. 10). Two anchoring 
elements are located at each end, both having disulfide groups allowing the wires to be 
attached to the electrodes. The center of the structure is a chimeric compound with a 
DNA segment that positions the element in the middle of the structure. It also contains 
biotin as a recognition group, isolated from the DNA by a spacer molecule made of two 
hexaethylenglycol units. This recognition element is used to direct a nanoparticle into 
the middle of the structure as well as to connect the two branches. The size of the whole 
structure is determined by the extension elements between the recognition and the 
anchoring elements. 
 
Figure 10 
 
The extension elements (100 bases long) were prepared using protocols to produce long 
oligonucleotides while thiolated oligonucleotides were prepared using standard 
protocols (de la Torre et al., 2002). Special protocols were developed for the preparation 
of the recognition elements since the polarity of the DNA strands is reversed in the 
middle of the molecule, thereby providing symmetry to the central assembly. The two-
armed recognition element was prepared by sequentially adding 10 different 
phosphoramidites. Starting from the 3’-end, the first half of the sequence was assembled 
using the four standard phosphoramidites. Subsequently, hexaethyleneglycol and biotin-
tetraethyleneglycol phosphoramidites were added. Finally, the second half of the 
molecule was assembled using the four reversed phosphoramidites (Grimau et al., 
2003). Synthesis of the oligonucleotides carrying three branches was conducted in 
similar fashion although a symmetric branching molecule was added. First, the 20 mer 
sequence was built in the 3´->5’ direction using standard phosphoramidites and the 
hexaethyleneglycol phosphoramidite. Then, the biotin-tetraethyleneglycol was added. 
Afterwards, a symmetric branching phosphoramidite was added to the sequence. 
Finally, the rest of the desired sequence was assembled in the 5’->3’ direction using 
reversed phosphoramidites and the hexaethyleneglycol phosphoramidite (Grimau et al., 
2003). 
Using these oligonucleotides the DNA-templated assembly of a protein-functionalized 
10 nm gap electrode, from suitably modified gold nanoparticles on a silicon wafer 
substrate, was achieved (Ongaro et al., 2004, Stanca et al., 2005, Stanca et al., 2006). 
This protein-functionalized electrode was recognized and selectively bound by a 
suitably modified gold nanoparticle that was localized in the 10 nm gap (Ongaro et al., 
2004, Stanca et al., 2005, Stanca et al., 2006). These findings are of interest for the 
fabrication of next-generation electronic devices. 
 
Concluding remarks 
Bruce Merrifield’s comments in his 1984 Nobel Lecture (“It soon become clear to me 
that … a new approach was needed if large numbers of peptides or if larger and more 
complex peptides were to be made”) are clearly applicable to oligonucleotide synthesis. 
At that time I began to work in this field, oligonucleotides synthesis that was becoming 
the robust method that is today. Efficient methods have been developed to produce a 
large variety of oligonucleotides and oligonucleotide-related derivatives that today are 
being used for a wide array of applications. In this review some of the developments in 
this field are described. The paradigm introduced by Merrifield’s visionary work is the 
production of large microarrays of oligonucleotides. A photolithographic system, in 
tandem with a light-sensitive group for the temporary protection of the 5’-hydroxyl 
allows for the massive, parallel synthesis of large numbers of oligonucleotide sequences 
on a surface, which following deprotection are ready for hybridization with 
complementary sequences. The actual methodology used for the production of these 
arrays can incorporate millions of oligonucleotides, enough to cover nearly an entire 
chromosome sequence, on a single chip. All these of developments only became 
possible after the introduction of solid-phase synthesis by Merrifield. 
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Figure Legends : 
 
Figure 1: Solid-phase synthesis of oligonucleotides using the phosphoramidite 
approach. (DMT: dimethoxytrityl, CE: cyanoethyl) 
 
Figure 2: Base-pairing schemes for the mispair between 5-substituted uracil derivatives 
and guanine; a) wobble base pair, b) ionized base pair, c) base pair involving enol 
tautomer. 
 
Figure 3: Outline of the preparation of phosphoramidite derivatives used for the 
synthesis of oligonucleotides carrying 2-aminopurine; a) and b) two methods involving 
transglycosylation appropriate for the introduction of 15N-labeled 2-aminopurine in 
oligonucleotides, c) methods involving reduction of guanosine derivatives. 
 
Figure 4: Chemical structures of nucleobases proposed as universal bases by several 
authors; a: hypoxanthine, b: xanthine, c: 2-azahypoxanthine, d: 8-aminohypoxanthine, 
e) 3-nitropyrrole, f) 5-nitroindole and g) 8-aza-7-deazaadenine. 
 
Figure 5: Strategies used for preparing oligonucleotides carrying O4-alkylythymine; a) 
the use of ammonia is not possible, unless the R group is sterically hindered, due to the 
nucleophilic displacement of the alcoxy group yielding 4-methylcytosine; b) 
oligonucleotides carrying O4-methyl, O4-ethyl, O4-propyl and O4-benzylthymines can 
be prepared using the corresponding alcoxide ions to remove the base protecting groups, 
c) the use of (p-nitrophenyl)ethyl (NPE) type groups allows the removal of these groups 
in conditions compatible with ammonia-sensitive molecules. 
 Figure 6: Synthesis of oligonucleotide-peptide conjugates by postsynthetic conjugation. 
The oligonucleotide and the peptide are built in a separate support using standard 
protocols but they are conveniently functionalized to be linked after synthesis. In this 
case the use of a maleimido peptide and a thiol-containing oligonucleotide is shown. 
 
Figure 7: Stepwise synthesis of oligonucleotide-peptide conjugates. The 
oligonucleotide-peptide conjugate is prepared in a single support using special 
protecting groups and modified protocols that minimize unwanted side-reactions. The 
scheme shows the synthesis of 3’-peptide oligonucleotide conjugates. The peptide is 
first assembled using t-butoxycarbonyl (Boc)-protected amino acids with base labile 
groups such as fluoren-9-ylmethyl (Fm), fluoren-9-ylmethoxycarbonyl (Fmoc), and 
trifluoroacetyl (TFA) groups to protect side chains. Oligonucleotide is assembled after 
the peptide using standard benzoyl (Bzl) and isobutyryl (ibu) groups to protect the 
nucleobases. PEG-PS: polyethyleneglycol-polystyrene support. 
 
Figure 8:  Schematic representation of 8-aminopurine triads; a)  8-aminoadenine: T: T, 
c) 8-aminoguanine:C:C+ and c) 8-aminohypoxanthine:C:C+. 
 
Figure 9: Schematic representation of oligonucleotide clamps designed to bind single-
stranded polypyrimidine sequences  (a-c) by triple helix formation. Bold dotted lines 
indicate Watson-Crick bonds. Thin dotted lines indicate Hoogsteen or reverse 
Hoogsteen bonds (TFO: triplex forming oligonucleotide sequence). 
 
Figure 10: a) Targeted oligonucleotide assemblies used as templates for gold 
nanostructures containing a biotin molecule used to direct a streptavidine molecule to 
the middle of the structure; b) outline of the synthesis for two- and three-branched 
recognition elements. 
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